|
|
Home > Healthcare > Biotechnology > General Biotech
Crucell N.V. - SWOT Analysis
|
| Published Date:
July 2008
Published By:
Datamonitor
Page Count:
26
Order Code:
R313-34063
|
|
|
|
Datamonitor's Crucell N.V. SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Crucell is a biotechnology company focused on discovering, developing and commercializing vaccines and antibodies against infectious diseases. The company’s product portfolio is focused on three distinct areas: pediatric, travel and endemic, and respiratory. The company is headquartered in Leiden, the Netherlands and employs more than 1,100 people. The company recorded revenues of E203.8 million (approximately $279.3 million) during the fiscal year (FY) ended December 2007, an increase of 54.9% over 2006. The increase is primarily attributable to the increase in sales of pediatric and travel vaccines and higher revenues related to the acquisitions of Berna Biotech and SBL Vaccines. The operating loss of the company was E51.6 million (approximately $70.7 million) during the FY2007, as compared to an operating loss of E97.9 million (approximately $134.1 million) during 2006. The net loss was E45.9 million (approximately $70 million) in the FY2007, as compared to a net loss of E87.6 million (approximately $119.6 million) in 2006.
Scope of the Report- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
Similar Products
• ImClone Systems Incorporated - SWOT Analysis
Published Sep 2008 by Datamonitor
• Pharmaceutical Manufacture and Sale
Published Sep 2008 by First Research, Inc.
• PDL Biopharma - SWOT Analysis
Published Sep 2008 by Datamonitor
• ImmunoGen, Inc - SWOT Analysis
Published Sep 2008 by Datamonitor
• Kendle International Inc. - SWOT Analysis
Published Sep 2008 by Datamonitor
• Neose Technologies, Inc. - SWOT Analysis
Published Sep 2008 by Datamonitor
• U.S. Chemical and Biological Detection Markets
Published Sep 2008 by Frost & Sullivan
• Global Biotechnology
Published Sep 2008 by Datamonitor
• Biotechnology in China
Published Sep 2008 by Datamonitor
• Biotechnology in Canada
Published Sep 2008 by Datamonitor
|
|
|
|
0 items
